The same research team further designed peptides with increased specificity, including the R-Tf-D-LP4 peptide, which contain a transferrin receptor internalization sequence (Tf) to promote the targeting of overexpressed transferrin receptor in cancer cells [86]. The gene discussed is TFRC; the disease is cancer.